,rsid,article_title,article_citation,article_authors,link
0,rs28930069,Dihydropyridine receptor mutations cause hypokalemic periodic paralysis,Cell,Ptácek LJ;Tawil R;Griggs RC;Engel AG;Layzer RB;Kwieciński H;McManis PG;Santiago L;Moore M;Fouad G;,https://www.ncbi.nlm.nih.gov/pubmed/8004673
1,rs28930069,ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing,Genetics in medicine : official journal of the American College of Medical Genetics,Green RC;Berg JS;Grody WW;Kalia SS;Korf BR;Martin CL;McGuire AL;Nussbaum RL;O'Daniel JM;Ormond KE;Rehm HL;Watson MS;Williams MS;Biesecker LG; ;,https://www.ncbi.nlm.nih.gov/pubmed/23788249
2,rs28930069,Primary structure of the receptor for calcium channel blockers from skeletal muscle,Nature,Tanabe T;Takeshima H;Mikami A;Flockerzi V;Takahashi H;Kangawa K;Kojima M;Matsuo H;Hirose T;Numa S;,https://www.ncbi.nlm.nih.gov/pubmed/3037387
3,rs28930069,Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A,Brain : a journal of neurology,Sternberg D;Maisonobe T;Jurkat-Rott K;Nicole S;Launay E;Chauveau D;Tabti N;Lehmann-Horn F;Hainque B;Fontaine B;,https://www.ncbi.nlm.nih.gov/pubmed/11353725
